Allogene Therapeutics Announces Exclusive Collaboration and Global License Agreement with Antion Biosciences for Multiplex miCAR(TM) Technology

Source :: GlobeNewswire. January 11, 2022
Publication Year :: 2022
Abstract: SOUTH SAN FRANCISCO, Calif. and GENEVA, Jan 11, 2022 (GLOBE NEWSWIRE via COMTEX) -- -- miCAR Platform Enables Simultaneous Silencing of Multiple Gene Targets -- Allogene to Deploy miCAR and [...]

Subjects :: Allogene Therapeutics Inc. -- Licensing agreements
Biotechnology industry -- Licensing agreements
Genetically modified organisms
Company licensing agreement
Banking, finance and accounting industries
Business

Tools